SDHB and sarcoma: SDH, positioned at the interface of the TCA cycle and the ETC, is typically portrayed by a panoply of loss-of-function mutations in sarcomas, which promote succinate accumulation, epigenetic dysregulation, and oncogenesis (21, 22, 37).